South San Francisco, CA, United States of America

Tina Giese

USPTO Granted Patents = 1 

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Inventor Spotlight: Tina Giese

Introduction

Tina Giese is an innovative inventor based in South San Francisco, California. With a focus on biotechnology, she has developed groundbreaking technologies aimed at addressing serious medical conditions.

Latest Patents

Tina holds a patent for her work titled "Fusion proteins comprising sulfoglucosamine sulfohydrolase enzymes and methods thereof." This patent outlines proteins capable of crossing the blood-brain barrier and incorporates sulfoglucosamine sulfohydrolase (SGSH) enzyme-Fc fusion polypeptides. Her innovative approach also includes methods to utilize these proteins for treating Sanfilippo syndrome A, a rare genetic disorder.

Career Highlights

Currently, Tina is employed by Denali Therapeutics Inc., a company renowned for its research and development in neurological conditions. Her contributions to the field of biotechnology highlight her commitment to improving patient outcomes through advanced scientific research.

Collaborations

Tina collaborates with esteemed colleagues Gunasekaran Kannan and Mihalis S Kariolis, combining their expertise to further explore the potential of her inventions in the industry. Together, they aim to advance their research and bring transformative solutions to the forefront of medicine.

Conclusion

Through her innovative efforts and impactful collaborations, Tina Giese is making significant strides in biotechnology. Her patent for protein therapies showcases her dedication to addressing complex medical challenges, particularly in treating Sanfilippo syndrome A. Her work at Denali Therapeutics Inc. continues to draw attention and holds promise for future developments in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…